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Native or denatured protein substrates which are hardly digested by thrombin can become much more effi- 
ciently cleaved by the enzyme after chemical modification of their carboxyl groups. Five antibody K-chains 
were used to demonstrate this effect. The selective cleavage sites were determined by quantitative N-terminal 
analysis and N-terminal sequencing. All five K-chains share the same cleavage sites at Arg-Thr (residues 
108-109), Arg-Glu (residues 142-143, Glu side chain modified with glycine amide), Lys-Ser (residues 207- 
208) and Arg-Gly (residues 21 I-212). One of the major cleavage sites (Arg-Thr) is located at the joint of 
the variable/constant region. The amino acids adjacent o these cleavage sites underline the proposed struc- 
tural requirements for a potential thrombin substrate [( 1985) Eur. J. B&hem. 151,2 17-2241. This approach 
can facilitate the application of thrombin in generating large polypeptide fragments of proteins. 
Proteolysis; Thrombin specificity; N-terminal analysis 
1. INTRODUCTION 
In analysis of the structure and function of pro- 
teins, it is often desirable to generate large 
polypeptide fragments. These large polypeptides 
are not only more suitable for sequencing by 
modern automatic instruments [l-3] but also 
generally more useful for delineation of the func- 
tional domain [4-61. Chemical methods which 
cleave selectively at the carboxyl end of methionine 
[7] and tryptophan [8,9] have been widely used. 
However, no enzymatic method with similarly 
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predicted specificity is available for routine pro- 
duction of large polypeptide fragments. 
Thrombin is a serine proteinase best known for 
its selective cleavage of two Arg-Gly bonds during 
fibrinogen-fibrin conversion [IO- 121. Thrombin 
also cleaves a large number of non-fibrinogen 
polypeptides with highly restricted specificities 
[ 13-171, and the amino acid sequences sur- 
rounding those selective cleavage sites were found 
to exhibit common structures (see [15] and section 
4). These data suggested that selective cleavage by 
thrombin can be reasonably predicted [IS]. We 
have indeed applied this predictability to isolate a 
pure variable region and a pure constant region 
from an antibody light chain [16]. Nonetheless, we 
have also found that not all Arg/Lys-X bonds 
with optimized structures can be effectively 
cleaved by thrombin. Here, we demonstrate that 
chemical modification of carboxyl groups of non- 
fibrinogen substrates can enhance their thrombin 
susceptibility. 
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2. MATERIALS AND METHODS 3. RESULTS 
Five human antibody x-chains were kindly pro- 
vided by Dr N. Hilschmann [ 18,191. The sources of 
DABITC, DABS-Cl, as well as other chemicals 
used in both N-terminal sequence and amino acid 
analyses were described in [20,21]. Bovine throm- 
bin was purchased from Serva. 
Proteins were oxidized using performic acid. 
Carboxyl groups were modified with glycine amide 
[22] and desalted by gel filtration (G-25) with 1 M 
acetic acid. The extent of modification was 
evaluated by amino acid analysis using the DABS- 
Cl pre-column derivatization method [23]. The 
ratios mol incorporated glycine amide/m01 car- 
boxy1 group in the five x-chains were found to be 
between 0.87 and 1.2, indicating quantitative 
modifications. Thrombin digestions were carried 
out under the conditions of 1 nmol substrate/O.5 
NIH unit thrombin in 35 ~1 of 50 mM ammonium 
bicarbonate at 25°C. The digestions were stopped 
by freeze-drying. The cleavage sites were deter- 
mined by sequence analysis using the DABITC/ 
PITC method [20]. The relative cleavage rates at 
each site were determined by quantitative N- 
terminal analysis [24] with the recovery of the N- 
terminus Asp as 100%. 
V, region 
2 4 
The extent of thrombin cleavage was first assess- 
ed with the technique of quantitative N-terminal 
analysis (fig.2). The selective cleavage sites were 
then determined by 4-8 steps of N-terminal se- 
quencing. For each protein, an 8 h and a 24 h 
digest were sequenced. This approach is suitable 
for analysing protein substrates with known amino 
acid sequences. However, with peptide mixtures as 
complex as those indicated in fig.2, there is a limit 
to which one can confidently assign all the minor 
cleavage sites, and it is likely that some minor 
cleavage sites which amounted to less than 10% of 
the major cleavage site may have been overlooked. 
The native x-chains (fig.1) are hardly digested by 
thrombin. None of the Arg/Lys-Xaa bonds in all 
five x-chains yield more than 30% of cleavage 
after 48 h of thrombin incubation (figs 2-4). 
Denaturation (by oxidation) does not significantly 
improve their thrombin susceptibility (figs 2-4). 
However, when oxidized chains were modified 
with glycine amide, several Arg/Lys-Xaa bonds 
were efficiently cleaved by thrombin (figs 2-4). 
For instance, when oxidized, glycine amide 
modified BI was digested by thrombin for 8 h 
(fig.2), four new N-termini, namely Glu (side chain 
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Fig. 1. Selective cleavage sites of antibody x-chains by thrombin. The x-chains were oxidized and their carboxyl groups 
modified with glycine amide. The major cleavage sites are indicated by large arrows and the minor cleavage sites by 
small arrows. VL, variable region of the light chain; CL, constant region of the light chain. 
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Fig.2. Quantitative N-terminal analysis (by the DABITC 
method) of antibody x-chain BI digested by thrombin 
for 8 h. (A) Oxidized and glycine amide modified. (B) 
Oxidized. (C) Native. A standard mixture of DABTH- 
amino acids is shown in the bottom panel. The released 
DABTH-amino acids were analysed by HPLC [20], and 
are symbolized by the one-letter code of their 
corresponding amino acids. SA, DABTH-dehydroserine; 
Dmod and Emod, DABTH-Asp and DABTH-Glu with 
their side chain carboxyl groups modified with glycine 
amide; U, thiourea by-product. 
time,h time,h 
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Fig.3. Selective thrombin cleavages of native, oxidized, 
oxidized plus modified BI at various Arg/Lys-Xaa 
bonds. The cleavage positions (see also fig.1) are 
indicated at the top left of each panel. Percentage 
cleavages were calculated based on the recovery of N- 
terminal DABTH-Asp as 100%. 
carboxyl group modified), Ser, Thr and Gly, ap- 
peared. Sequence analysis indicates that Glu was 
derived from cleavage of Phe Tyr Pro Arg-Glu 
(142-143), Ser from that of Pro Val Thr Lys-Ser 
(207-208), Thr from that of Glu* Ile Lys Arg-Thr 
(108-109) (* glycine amide modified) and Gly 
from the combined cleavages of Ser Arg Phe 
Arg-Gly (63-64) and Ser Phe Asn Arg-Gly 
(211-212). This enhanced thrombin susceptibility 
was also found with modified AU, HAU, ROY 
and CUM, and the same cleavage sites were found 
within their constant regions (fig.1). One in- 
teresting major cleavage site detected within all 
five x-chains was Arg-Thr (108-109). This bond is 
located at the joint of the variable region and con- 
stant region. Since no major cleavage sites were 
identified within the variable regions of AU, 
HAU, ROY and CUM, the selective cleavage at 
Arg-Thr may be used to prepare the intact variable 
regions for some light chains. We have not in- 
vestigated this enhanced effect on the carboxy- 
methylated x-chains. But in a separate study [16], 
it has been shown that both oxidized and carboxy- 
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time,h 
Fig.4. Selective thrombin cleavages of native, oxidized, 
oxidized plus modified BI at two Arg-Gly bonds. 
Percentage cleavages were calculated based on the 
recovery of N-terminal DABTH-Asp as 100%. 
methylated x-chains were cleaved by thrombin 
with indistinguishable specificities and efficiencies. 
4. DISCUSSION 
Although thrombin cleaves both fibrinogen and 
non-fibrinogen substrates with high specificity, it 
does so with vastly different efficiencies. Even the 
best polypeptide hormone substrate (gastrin- 
releasing peptide) [15] has a Kcat/Km value one to 
two orders of magnitude lower than that of 
fibrinogen h chain. Studies employing chemical- 
ly modified thrombin [25] and autolysed thrombin 
[17,26,27] have revealed that mechanisms for the 
selective cleavages of fibrinogen and non- 
fibrinogen substrates are governed at two different 
levels [ 15,171. Selective cleavage of non-fibrinogen 
substrate requires the intact active site of thrombin 
only. Selective cleavage of fibrinogen requires in 
addition to the active site an independent recogni- 
tion site which is made up by clusters of basic 
amino acids [ 11,13,17,30]. This recognition site 
can be disrupted without major effect on its active 
site. Thus, a thrombin derivative devoid of clotting 
activity but still retaining almost full activity 
toward non-fibrinogen substrates can be prepared 
time, h 
Fig.5. Selective thrombin cleavage at the Arg-Thr 
(positions 108-109) of five antibody x-chains (all 
oxidized and glycine amide modified). 1, CUM. 2, AU. 
3, BI. 4, HAU. 5, ROY. 
by chemical modification [25] or autolysis 
[17,26,27]. 
Documented thrombin-susceptible bonds 
(P4-P3-P2-Arg/Lys-P 1’ -P2 ’ ) of non-fibrinogen 
substrates can be grouped based on the structures 
adjacent o the cleavage sites, and this information 
can be applied to predict, at least qualitatively, the 
potential thrombin cleavage site in polypeptides 
with known sequences [ 151. (i) The most abundant 
cases have Pro at the P2 position, hydrophobic 
amino acids at positions P3-P4 and non-acidic 
amino acids at positions PI ’ or P2 ’ . (ii) A Ser or 
Thr at position Pl ’ will enhance thrombin 
cleavage of those with optimized P2-P4 structures 
described above. (iii) Those with Gly at positions 
Pl’ or P2 are also preferential thrombin 
substrates. These unique proteolytic specificities 
have been attributed to the constrained catalytic 
site and a hydrophobic binding pocket adjacent to 
it [13,15,17,28,29]. 
The thrombin cleavage sites identified within the 
chemically modified x-chains have surrounding se- 
quences which comply with the above-mentioned 
structural requirements (fig. 1). Among the five 
major cleavage sites detected within BI (with 50% 
cleavage time of approx. 4-8 h), two have Gly at 
position P 1’ , two have Ser or Thr at position P 1’ 
and the other has Pro and hydrophobic amino 
acids at positions P2-P4. The Pro Arg-Glu was 
digested by thrombin only after Glu had been 
modified with glycine amide. Most minor cleavage 
sites identified within variable regions also have 
9 
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Pro, Gly or hydrophobic residues at the P2 posi- 
tion. However, those minor cleavages (with 50% 
cleavage time on average longer than 72 h under 
described conditions) are insignificant as com- 
pared to most documented thrombin cleavage sites 
[11,15]. 
It is likely that chemical modification at carbox- 
yl groups with glycine amide could further 
denature the oxidized proteins. However, we 
believe that this enhanced susceptibility underlines 
the importance of the hydrophobic binding pocket 
in thrombin [17,28,29]. Modification of carboxyl 
groups could in general facilitate the interactions 
of the polypeptide substrates with the hydrophobic 
binding site in thrombin. 
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